Weiner HL - Search Results

1

Alterations of the human gut microbiome in multiple sclerosis.

Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, Cook S, Tankou S, Stuart F, Melo K, Nejad P, Smith K, Topçuolu BD, Holden J, Kivisäkk P, Chitnis T, De Jager PL, Quintana FJ, Gerber GK, Bry L, Weiner HL. Jangi S, et al. Among authors: weiner hl. Nat Commun. 2016 Jun 28;7:12015. doi: 10.1038/ncomms12015. Nat Commun. 2016. PMID: 27352007 Free PMC article.

2

Inflammation and therapeutic vaccination in CNS diseases.

Weiner HL, Selkoe DJ. Weiner HL, et al. Nature. 2002 Dec 19-26;420(6917):879-84. doi: 10.1038/nature01325. Nature. 2002. PMID: 12490962 Review.

3

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Viglietta V, et al. Among authors: weiner hl. J Exp Med. 2004 Apr 5;199(7):971-9. doi: 10.1084/jem.20031579. J Exp Med. 2004. PMID: 15067033 Free PMC article.

4

Immunosuppressive treatment in multiple sclerosis.

Weiner HL. Weiner HL. J Neurol Sci. 2004 Aug 15;223(1):1-11. doi: 10.1016/j.jns.2004.04.013. J Neurol Sci. 2004. PMID: 15261554

5

Immunosuppressive therapy for multiple sclerosis.

Gauthier SA, Buckle GJ, Weiner HL. Gauthier SA, et al. Among authors: weiner hl. Neurol Clin. 2005 Feb;23(1):247-72, viii-ix. doi: 10.1016/j.ncl.2004.09.007. Neurol Clin. 2005. PMID: 15661097 Review. No abstract available.

6

A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.

Smith DR, Weinstock-Guttman B, Cohen JA, Wei X, Gutmann C, Bakshi R, Olek M, Stone L, Greenberg S, Stuart D, Orav J, Stuart W, Weiner H. Smith DR, et al. Mult Scler. 2005 Oct;11(5):573-82. doi: 10.1191/1352458505ms1210oa. Mult Scler. 2005. PMID: 16193896 Clinical Trial.

7

Understanding natural and pathological autoimmunity.

Quintana FJ, Weiner HL. Quintana FJ, et al. Among authors: weiner hl. J Neuroimmunol. 2006 May;174(1-2):1-2. doi: 10.1016/j.jneuroim.2006.02.003. Epub 2006 Mar 13. J Neuroimmunol. 2006. PMID: 16533538 No abstract available.

8

Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso AS, Wu H, Chen ML, Gandhi R, Miller A, Maron R, Weiner HL. Ochi H, et al. Among authors: weiner hl. Nat Med. 2006 Jun;12(6):627-35. doi: 10.1038/nm1408. Epub 2006 May 21. Nat Med. 2006. PMID: 16715091

9

IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production.

Vaknin-Dembinsky A, Balashov K, Weiner HL. Vaknin-Dembinsky A, et al. Among authors: weiner hl. J Immunol. 2006 Jun 15;176(12):7768-74. doi: 10.4049/jimmunol.176.12.7768. J Immunol. 2006. PMID: 16751425

10

Cutting Edge: Immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner.

Gandhi R, Anderson DE, Weiner HL. Gandhi R, et al. Among authors: weiner hl. J Immunol. 2007 Apr 1;178(7):4017-21. doi: 10.4049/jimmunol.178.7.4017. J Immunol. 2007. PMID: 17371954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

842 results

Search Page

Filters